321 related articles for article (PubMed ID: 24089228)
1. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells.
Xu YB; Du QH; Zhang MY; Yun P; He CY
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2486-94. PubMed ID: 24089228
[TBL] [Abstract][Full Text] [Related]
2. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
3. Propofol suppresses invasion, angiogenesis and survival of EC-1 cells in vitro by regulation of S100A4 expression.
Guo XG; Wang S; Xu YB; Zhuang J
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4858-65. PubMed ID: 26744878
[TBL] [Abstract][Full Text] [Related]
4. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
5. Propofol Suppresses Esophageal Squamous Cell Carcinoma Cell Migration and Invasion by Down-Regulation of Sex-Determining Region Y-box 4 (SOX4).
Zhou CL; Li JJ; Ji P
Med Sci Monit; 2017 Jan; 23():419-427. PubMed ID: 28118321
[TBL] [Abstract][Full Text] [Related]
6. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERK‑mediated VEGF‑VEGFR2 signaling pathway.
Li CH; Sun XJ; Niu SS; Yang CY; Hao YP; Kou JT; Li XZ; Wang XX
Oncol Rep; 2018 Sep; 40(3):1795-1802. PubMed ID: 30015941
[TBL] [Abstract][Full Text] [Related]
9. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Chetty C; Lakka SS; Bhoopathi P; Kunigal S; Geiss R; Rao JS
Cancer Res; 2008 Jun; 68(12):4736-45. PubMed ID: 18559520
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells.
Park BC; Thapa D; Lee JS; Park SY; Kim JA
J Pharmacol Sci; 2009 Sep; 111(1):1-12. PubMed ID: 19763043
[TBL] [Abstract][Full Text] [Related]
12. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells.
Wu KC; Yang ST; Hsia TC; Yang JS; Chiou SM; Lu CC; Wu RS; Chung JG
Anticancer Res; 2012 Nov; 32(11):4833-42. PubMed ID: 23155249
[TBL] [Abstract][Full Text] [Related]
13. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4.
Rah B; Amin H; Yousuf K; Khan S; Jamwal G; Mukherjee D; Goswami A
PLoS One; 2012; 7(9):e44039. PubMed ID: 22962598
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling.
Donnini S; Monti M; Castagnini C; Solito R; Botta M; Schenone S; Giachetti A; Ziche M
Int J Cancer; 2007 Mar; 120(5):995-1004. PubMed ID: 17131343
[TBL] [Abstract][Full Text] [Related]
16. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
17. Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways.
Zhao HJ; Liu T; Mao X; Han SX; Liang RX; Hui LQ; Cao CY; You Y; Zhang LZ
Acta Pharmacol Sin; 2015 Jun; 36(6):758-68. PubMed ID: 25864648
[TBL] [Abstract][Full Text] [Related]
18. Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling.
Tantai JC; Zhang Y; Zhao H
Mol Med Rep; 2016 Feb; 13(2):1097-104. PubMed ID: 26647768
[TBL] [Abstract][Full Text] [Related]
19. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
[TBL] [Abstract][Full Text] [Related]
20. GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells.
Miao Y; Zhang Y; Wan H; Chen L; Wang F
Biomed Pharmacother; 2010 Nov; 64(9):583-8. PubMed ID: 20888181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
